Editorial Comment
- PMID: 33687276
- DOI: 10.1097/JU.0000000000001574.01
Editorial Comment
Comment in
-
Reply by Authors.J Urol. 2021 May;205(5):1429. doi: 10.1097/JU.0000000000001574.02. Epub 2021 Mar 9. J Urol. 2021. PMID: 33687277 No abstract available.
Comment on
-
Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy from a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR).J Urol. 2021 May;205(5):1421-1429. doi: 10.1097/JU.0000000000001574. Epub 2020 Dec 28. J Urol. 2021. PMID: 33356445 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources